Literature DB >> 11359966

A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

M Clark1, B Cooper, S Singh, M Cooper, A Carr, R Hubbard.   

Abstract

BACKGROUND: A survey of overnight oximetry was conducted to estimate the prevalence of nocturnal hypoxaemia in patients with cryptogenic fibrosing alveolitis and to establish whether nocturnal hypoxaemia is related to quality of life.
METHODS: All patients with cryptogenic fibrosing alveolitis attending Nottingham City Hospital were invited to enter the study. Spirometric measurements and capillary blood gas tensions were obtained and overnight oxygen saturation was recorded at home. Quality of life was assessed using the Short Form-36, Chronic Respiratory Questionnaire, Hospital Anxiety Depression Scale, and Epworth Sleepiness Score questionnaires.
RESULTS: Sixty seven eligible patients were identified and 50 agreed to enter the study, although two were subsequently excluded because they already used oxygen overnight. In the remaining 48 the mean (SD) overnight oxygen saturation (SaO(2)) was 92.5 (4.3)% and the median number of dips greater than 4% per hour was 2.3 (interquartile range 1.5-5.3). Daytime oxygen level predicted mean overnight SaO(2) (1.94%/kPa, 95% CI 1.22 to 2.66, p<0.001) but percentage predicted forced vital capacity (FVC) did not (0.018%/% predicted FVC, 95% CI -0.04 to 0.08, p=0.5). Nocturnal hypoxaemia was associated with decreased energy levels and impaired daytime social and physical functioning, and these effects were independent of FVC.
CONCLUSIONS: Nocturnal hypoxaemia is common in patients with cryptogenic fibrosing alveolitis and may have an impact on health related quality of life.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359966      PMCID: PMC1746078          DOI: 10.1136/thorax.56.6.482

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.

Authors:  R Hubbard; A Venn; S Lewis; J Britton
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

3.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

4.  Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity.

Authors:  A Schnabel; M Reuter; E Csernok; C Richter; W L Gross
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

5.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.

Authors:  M A Johnson; S Kwan; N J Snell; A J Nunn; J H Darbyshire; M Turner-Warwick
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

6.  Studies of oxygenation during sleep in patients with interstitial lung disease.

Authors:  P T Bye; F Issa; M Berthon-Jones; C E Sullivan
Journal:  Am Rev Respir Dis       Date:  1984-01

7.  Breathing during sleep in patients with interstitial lung disease.

Authors:  R Perez-Padilla; P West; M Lertzman; M H Kryger
Journal:  Am Rev Respir Dis       Date:  1985-08

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Cryptogenic fibrosing alveolitis and lung cancer.

Authors:  M Turner-Warwick; M Lebowitz; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

10.  Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease.

Authors:  W Cormick; L G Olson; M J Hensley; N A Saunders
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

View more
  15 in total

1.  Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.

Authors:  Likurgos Kolilekas; Effrosyni Manali; Katerina A Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos N Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

2.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

Review 3.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

4.  The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference.

Authors:  Jeffrey J Swigris; Frederick S Wamboldt; Juergen Behr; Roland M du Bois; Talmadge E King; Ganesh Raghu; Kevin K Brown
Journal:  Thorax       Date:  2009-12-08       Impact factor: 9.139

5.  Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.

Authors:  Kathleen Oare Lindell; Ellen Olshansky; Mi-Kyung Song; Thomas G Zullo; Kevin F Gibson; Naftali Kaminski; Leslie A Hoffman
Journal:  Heart Lung       Date:  2009-11-20       Impact factor: 2.210

6.  Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease.

Authors:  Manju Pillai; Amy L Olson; Tristan J Huie; Joshua J Solomon; Evans R Fernandez-Perez; Kevin K Brown; Phillip Hanna; Teofilo Lee-Chiong; Jeffrey J Swigris
Journal:  Respir Med       Date:  2012-04-20       Impact factor: 3.415

Review 7.  Sleep disordered breathing in interstitial lung disease: A review.

Authors:  Lauren K Troy; Tamera J Corte
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

8.  Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Jeffrey Chapman; Joseph Golish; Demetrios Mermigkis; Kumaraswamy Budur; Antony Kopanakis; Vlassis Polychronopoulos; Richard Burgess; Nancy Foldvary-Schaefer
Journal:  Lung       Date:  2007-04-10       Impact factor: 3.777

9.  Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.

Authors:  Jeffrey J Swigris; Anita L Stewart; Michael K Gould; Sandra R Wilson
Journal:  Health Qual Life Outcomes       Date:  2005-10-07       Impact factor: 3.186

Review 10.  Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.

Authors:  Ayodeji Adegunsoye; Jay Balachandran
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.